Nicotinamide riboside (NR)
Six weeks of oral NR raised NAD+ in blood cells by about 60% in healthy adults aged 55 to 79, and was well tolerated (Martens et al., 2018).
Evidence, not hype
NAD+ is essential to every cell, and early studies are encouraging. Here's what human research has actually found, what's still unproven, and what you can count on from NADMedics.
Medically reviewed by Vanessa Niles, R.N., M.D., F.A.C.O.G. —
What studies show
Small, mostly short trials. Most used precursors taken by mouth, not NAD+ injections or spray.
Six weeks of oral NR raised NAD+ in blood cells by about 60% in healthy adults aged 55 to 79, and was well tolerated (Martens et al., 2018).
In a 60-day trial of 80 adults, 300 to 900 mg a day of oral NMN raised blood NAD and improved six-minute walking distance versus placebo (Yi et al., 2023).
Ten weeks of NMN increased muscle insulin sensitivity by about 25% in women with prediabetes, according to an NIH summary (Yoshino et al., 2021).
In the phase I NADPARK trial, 30 days of oral NR raised brain NAD levels and was well tolerated (Brakedal et al., 2022).
A pilot trial found NR roughly doubled whole-blood NAD+ and appeared safe in people with heart failure (Wang et al., 2022).
A six-hour, 750 mg IV infusion in healthy men raised plasma NAD+ by the end, with no adverse events during the infusion (Grant et al., 2019).
The big picture
NAD+ is a coenzyme more than 400 enzymes need, and research reviews describe its levels falling in several tissues with age. That’s why scientists study it.
Raising NAD+ in blood is one thing; improving how people feel or age is another. That second step hasn’t been proven yet. See our conditions page for where research is heading.
You’ll see these in NAD+ marketing. No clinical trial has shown them:
Questions
Not directly. Most trials used oral precursors (NR or NMN), and one used IV NAD+. Human studies of NAD+ injections under the skin or nasal spray are very limited.
There's no reliable timeline. Some people describe changes within weeks; others notice nothing. Your provider checks in so you can decide together.
That's a personal decision. Short studies suggest NAD+ and its precursors are generally tolerated, but long-term data are missing. A provider can help you weigh it.
Its role as a coenzyme: NAD+ helps turn food into usable energy and is used by enzymes involved in DNA repair. More than 400 enzymes need it, according to NIH.
No clinical trial has shown that NAD+ therapy causes weight loss.
That hasn't been shown. Some people find doses taken late in the day keep them awake, so timing can matter.
Keep learning
Official sources
Official government and research sources behind this page, so you can check the facts yourself.
Randomized crossover trial of oral NR in healthy adults.
60-day randomized trial of 300, 600 and 900 mg/day oral NMN.
10-week randomized trial of oral NMN.
NIH summary of the 2021 NMN trial in women with prediabetes.
Phase I trial: oral NR raised brain NAD levels and was well tolerated.
Pilot trial: NR roughly doubled whole-blood NAD+ and appeared safe.
Small pilot study of intravenous NAD+ in healthy adults.
Review of how NAD+ works in cells and how levels change with age.
Weighs early promise against the lack of long-term human trials.
Medically reviewed by Dr. Vanessa Niles, R.N., M.D., F.A.C.O.G., on October 12, 2026. NAD+ has no FDA-approved use; compounded NAD+ is not FDA-approved or evaluated for safety or effectiveness. Results in studies may not apply to you.
Book a free online consultation. If a provider prescribes NAD+, plans start from $166 a month.
Book a free consultation